Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset——Joint poster with Bachem demonstrates ...

Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...

Wastewater in several Californian cities, including San Francisco and Los Angeles, recently tested positive for bird flu. But ...

A new study presents "Evo" – a machine learning model capable of decoding and designing DNA, RNA, and protein sequences, from ...

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...

With the help of an expert, we explore the role this essential nutrient plays in the body and when and how it should be taken ...

Researchers from VIB and VUB now provide an interactive tool, based on a single-cell RNA-sequencing (scRNA-seq) atlas of the ...

Mithrl, an AI-powered platform revolutionizing scientific research, today announced a $4 million seed round to evolve the research and development process for scientific innovation globally. The round ...

Tumor/normal exome sequencing and tumor RNA sequencing were used to identify expressed somatic mutations; cancer neoantigens ...

Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...

Shares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its current RNA-based pipeline of rare muscle disorders to explore a new therapeutic ...